来自第三代EGFR-TKI的化学探针作为针对性治疗的潜在伴侣诊断工具
Qian Lei1,2,3,4, Ying Li1,2,3,4, Chao Song1,2,3,4
1Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610065, China.
ACS chemical biology
|January 15, 2026
概括
开发了针对表皮生长因子受体 (EGFR) 激酶的新化学探针. 这些基于第三代EGFR-TKIs的探针可以在肺癌模型和患者样本中可视化活性EGFR突变.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 第三代EGFR-TKI如AZD9291对EGFR突变非小细胞肺癌 (NSCLC) 有效,包括获得的耐药性.
- 目前的基因测试可以识别突变,但不能确定EGFR激酶的功能状态,这对治疗疗效至关重要.
- 需要工具来评估EGFR激酶活性,以进行个性化肺癌治疗.
研究的目的:
- 开发针对EGFR激酶活性位点的新型化学探针.
- 评估这些探针在临床前和临床环境中的选择性和实用性.
- 探索这些探针作为个性化NSCLC治疗的伴侣诊断的潜力.
主要方法:
- 通过对第三代EGFR-TKI (AZD9291, PF-06747775) 结合基或光标签来合成化学探针.
- 在体外生化分析和细胞研究以评估探针选择性和EGFR激酶抑制.
- 使用异种移植小鼠模型的体内研究和临床肺癌样本的分析.
主要成果:
- 与AZD9291-yne (探针3) 相比,PF-06747775-yne (探针4) 对EGFR激酶具有更高的选择性.
- 光标记AZD9291增强了其对EGFR激酶的选择性.
- PF-06747775-yne在小鼠模型和人类肺癌组织中成功可视化了活跃的EGFR突变物.
结论:
- 基于PF-06747775的化学探针是准和可视化活性EGFR激酶的有效工具.
- 这些探针显示出有前途的潜力,作为伴侣诊断指导NSCLC个性化治疗策略.
- 开发的探针提供了一种有价值的方法来评估EGFR功能状态,而不仅仅是简单的突变检测.
更多相关视频
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
8.3K
10:57Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
Published on: August 14, 2018
11.2K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K